Clinical trial
Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients…
NCT00221546 · University Hospital, Ghent, Other · Completed
Key facts
| NCT number | NCT00221546 |
|---|---|
| Title | Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis |
| Official title | Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis |
| Lead sponsor | University Hospital, Ghent, Other |
| Collaborators | Belgian Society against Cystic Fibrosis |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Giving DHA-rich supplement |
| Enrollment | 17 |
| Start date | Sep 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 28, 2011 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: